NCT06665815View on ClinicalTrials.gov

A National Screening Program for Islet Autoantibodies Among First-degree Relatives of T1D Patients

RecruitingOBSERVATIONAL

Enrollment

20,000

Participants

Timeline

Start Date

December 15, 2024

Primary Completion Date

December 15, 2027

Study Completion Date

February 15, 2028

Conditions

Type 1 DiabetesAutoantibodies Screening

Trial Locations (1)

Unknown

RECRUITING

Schneider Children Medical Center of Israel, Petah Tikva

All Listed Sponsors

lead

Rabin Medical Center

OTHER